The Feasibility of Magnetic Resonance Imaging in a Non-Selective Comprehensive Clinical Trial in Pediatric Autism Spectrum Disorder.
Marilena M DeMayoIzabella PokorskiYun J C SongRinku ThapaShrujna PatelZahava AmbarchiDomenic SoligoIndra SadeliEmma E ThomasIan B HickieAdam John GuastellaPublished in: Journal of autism and developmental disorders (2021)
There is an increasing interest in using magnetic resonance imaging (MRI) as a tool for precision medicine in autism spectrum disorder (ASD). This study investigated the feasibility of MRI scanning in a large comprehensive, inclusive and test heavy clinical trial for children (aged 3-12 years) with ASD, without functioning constraints for participation. Of the 71 participants enrolled who consented to the MRI, 24 participants (38%) successfully completed an MRI scan at baseline along with other assessments. This scanning followed a familiarization procedure at two preceding visits. At post-treatment, 21 participants successfully completed the MRI scan. This study highlights the challenge of completing MRI assessments in ASD populations when conducted as one of a number of tests in a clinical trial.
Keyphrases
- autism spectrum disorder
- magnetic resonance imaging
- contrast enhanced
- clinical trial
- diffusion weighted imaging
- computed tomography
- attention deficit hyperactivity disorder
- intellectual disability
- magnetic resonance
- high resolution
- phase ii
- physical activity
- study protocol
- minimally invasive
- mass spectrometry
- atomic force microscopy
- high speed